# 🧬 Comparative TP53 Sequence Analysis

## Comparative In-Silico Analysis of TP53 Mutation Hotspots Between Humans and Elephants

**Research Project:** Elephant TP53 Hotspot Mapping  
**Researcher:** Ritika Rajendra Rawat  
**Degree:** MSc Bioinformatics  
**Institution:** University of Mumbai  

---

## 🔬 Research Objective

This notebook implements a reproducible comparative sequence-analysis
workflow for examining TP53-related protein sequences from humans and
elephants.

The analysis focuses on:

- sequence quality control;
- reference-sequence identification;
- global protein sequence comparison;
- sequence identity;
- alignment-aware residue mapping;
- canonical human TP53 hotspot positions;
- comparative sequence features;
- and exploratory visualization.

### Canonical TP53 hotspot positions

- R175
- G245
- R248
- R249
- R273
- R282

> This notebook performs comparative bioinformatics analysis. It is not a
> clinical diagnostic system, cancer-risk predictor, or validated model of
> elephant cancer resistance.

# 📚 Scientific Background

TP53 encodes the tumor-suppressor protein p53, a central regulator of
cell-cycle control, DNA-damage responses, apoptosis and genomic stability.

Recurrent mutations in TP53 are frequently observed in human cancers.
Comparative analysis of TP53-related sequences across species provides a
computational framework for investigating sequence conservation and
divergence at biologically important residues.

The purpose of this analysis is to characterize sequence-level relationships
that can motivate subsequent evolutionary, structural and functional studies.

Sequence conservation alone should not be interpreted as evidence of
functional equivalence or a causal mechanism of cancer susceptibility.

# 🎯 Canonical TP53 Hotspots

The following human TP53 hotspot positions are used as reference
coordinates:

| Position | Hotspot |
|---:|---|
| 175 | R175 |
| 245 | G245 |
| 248 | R248 |
| 249 | R249 |
| 273 | R273 |
| 282 | R282 |

The reference residue is verified directly against the human TP53 sequence
before comparative mapping.

Residue correspondence is determined using sequence alignment rather than
assuming that the same numerical position necessarily represents the same
evolutionary position in another sequence.

# 🔬 Results Interpretation

The computational workflow provides sequence-level measurements describing:

1. similarity between analyzed sequences and human TP53;
2. alignment-aware correspondence of canonical TP53 hotspot positions;
3. conservation or divergence at these positions; and
4. broader amino-acid composition characteristics.

These findings should be interpreted as comparative sequence observations.

They do not establish:

- elephant cancer resistance;
- functional equivalence of TP53-related sequences;
- altered tumor-suppressor activity;
- clinical protection;
- or a causal mechanism of cancer susceptibility.

Such conclusions require additional evolutionary, structural, functional,
and experimental evidence.

# ⚠️ Limitations

- Sequence conservation does not necessarily imply functional equivalence.
- TP53-related sequences may represent canonical genes, duplicates,
  or retrogene-like copies with different biological contexts.
- Sequence-level analysis does not measure protein expression or biochemical
  activity.
- Hotspot conservation alone cannot establish cancer susceptibility.
- The current workflow is computational and requires biological validation.
- Results depend on the reference sequences and preprocessing choices.
- Pairwise alignment is appropriate for exploratory comparison but should
  be complemented by broader evolutionary analyses for phylogenetic claims.

 # 🔄 Reproducibility

### Input

```text
data/processed/TP53_clean.fasta 




